Evidence map›Paper›PMID 35383362›Full record

ArticleBriefings in bioinformatics2022

Predicting the binding of small molecules to nuclear receptors using machine learning.

Azhagiya Singam Ettayapuram Ramaprasad, Martyn T Smith, David McCoy, Alan E Hubbard, Michele A La Merrill, Kathleen A Durkin

Open access · bronzeAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Environmental science & technology · 2025
    Review
  5. Article
  6. Article
  7. Mapping assays to the key characteristics of carcinogens to support decision-making.Database : the journal of biological databases and curation · 2025
    Article
  8. The key characteristics concept.Current opinion in toxicology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Azhagiya Singam Ettayapuram RamaprasadMolecular Graphics and Computation Facility, College of Chemistry, University of California, Berkeley, CA 94720, USA.
Martyn T SmithDivisions of Environmental Health Sciences and Biostatistics, School of Public Health, University of California Berkeley, CA 94720, USA.
David McCoyDivisions of Environmental Health Sciences and Biostatistics, School of Public Health, University of California Berkeley, CA 94720, USA.
Alan E HubbardDivisions of Environmental Health Sciences and Biostatistics, School of Public Health, University of California Berkeley, CA 94720, USA.
Michele A La MerrillDepartment of Environmental Toxicology, University of California, Davis, CA 95616, USA.
Kathleen A DurkinMolecular Graphics and Computation Facility, College of Chemistry, University of California, Berkeley, CA 94720, USA.ORCID 0000-0003-1282-6101
University of California, Berkeley · USUniversity of California, Davis · US

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI MCHALE, CLIONA · 1987 to 2025
$74.6M
High Performance Computing Cluster for Public Health Driven Molecular Science - Core FacilityS10OD023532 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI DURKIN, KATHLEEN A · 2017 to 2017
$434k
NIEHS NIH HHS P42 ES004705NIH HHS S10 OD023532
6 · The paper itself

Abstract

Nuclear receptors (NRs) are important biological targets of endocrine-disrupting chemicals (EDCs). Identifying chemicals that can act as EDCs and modulate the function of NRs is difficult because of the time and cost of in vitro and in vivo screening to determine the potential hazards of the 100 000s of chemicals that humans are exposed to. Hence, there is a need for computational approaches to prioritize chemicals for biological testing. Machine learning (ML) techniques are alternative methods that can quickly screen millions of chemicals and identify those that may be an EDC. Computational models of chemical binding to multiple NRs have begun to emerge. Recently, a Nuclear Receptor Activity (NuRA) dataset, describing experimentally derived small-molecule activity against various NRs has been created. We have used the NuRA dataset to develop an ensemble of ML-based models to predict the agonism, antagonism, binding and effector binding of small molecules to nine different human NRs. We defined the applicability domain of the ML models as a measure of Tanimoto similarity to the molecules in the training set, which enhanced the performance of the developed classifiers. We further developed a user-friendly web server named 'NR-ToxPred' to predict the binding of chemicals to the nine NRs using the best-performing models for each receptor. This web server is freely accessible at http://nr-toxpred.cchem.berkeley.edu. Users can upload individual chemicals using Simplified Molecular-Input Line-Entry System, CAS numbers or sketch the molecule in the provided space to predict the compound's activity against the different NRs and predict the binding mode for each.

Indexed as

Endocrine DisruptorsReceptors, Cytoplasmic and NuclearHumansMachine LearningEndocrine DisruptorsReceptors, Cytoplasmic and NuclearMachine learningNuclear ReceptorSuper LearnerToxicity

Identifiers

PMID35383362
PMCPMC9116378
OpenAlexW4226079108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.